|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Advanced Cell Technology Inc., of Alameda, Calif., plans to privately offer up to $11.29 million of senior secured convertible debentures and warrants. The timing of the closing of the offering will be subject to market conditions, and proceeds will be used for general corporate purposes, which may include repayment of debt and additions to working capital.
o Althea Technologies Inc., of San Diego, was awarded a contract from Altus Pharmaceuticals Inc., of Cambridge, Mass., to produce its ALTU-238 product candidate, a crystallized formulation of human growth hormone that is designed to be administered once-weekly through a fine-gauge needle to treat HGH ...